These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 7702558)
21. Aggregation-induced activation of the epidermal growth factor receptor protein tyrosine kinase. Mohammadi M; Honegger A; Sorokin A; Ullrich A; Schlessinger J; Hurwitz DR Biochemistry; 1993 Aug; 32(34):8742-8. PubMed ID: 8395880 [TBL] [Abstract][Full Text] [Related]
22. Alteration of the kinetic properties of the epidermal growth factor receptor tyrosine kinase by basic proteins. Hubler L; Leventhal PS; Bertics PJ Biochem J; 1992 Jan; 281 ( Pt 1)(Pt 1):107-14. PubMed ID: 1370607 [TBL] [Abstract][Full Text] [Related]
23. Glycosylation-induced conformational modification positively regulates receptor-receptor association: a study with an aberrant epidermal growth factor receptor (EGFRvIII/DeltaEGFR) expressed in cancer cells. Fernandes H; Cohen S; Bishayee S J Biol Chem; 2001 Feb; 276(7):5375-83. PubMed ID: 11087732 [TBL] [Abstract][Full Text] [Related]
24. Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity. Guy PM; Platko JV; Cantley LC; Cerione RA; Carraway KL Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8132-6. PubMed ID: 8058768 [TBL] [Abstract][Full Text] [Related]
25. Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612. De Fea K; Roth RA Biochemistry; 1997 Oct; 36(42):12939-47. PubMed ID: 9335553 [TBL] [Abstract][Full Text] [Related]
26. Conformational analysis of the phosphorylated epidermal growth factor receptor. Bishayee A; Beguinot L; Bishayee S Biosci Rep; 1999 Oct; 19(5):397-402. PubMed ID: 10763807 [TBL] [Abstract][Full Text] [Related]
27. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. Ferguson KM; Berger MB; Mendrola JM; Cho HS; Leahy DJ; Lemmon MA Mol Cell; 2003 Feb; 11(2):507-17. PubMed ID: 12620237 [TBL] [Abstract][Full Text] [Related]
28. The calpain cleavage sites in the epidermal growth factor receptor kinase domain. Gregoriou M; Willis AC; Pearson MA; Crawford C Eur J Biochem; 1994 Jul; 223(2):455-64. PubMed ID: 8055914 [TBL] [Abstract][Full Text] [Related]
29. Interleukin-1 activates a novel protein kinase that phosphorylates the epidermal-growth-factor receptor peptide T669. Kracht M; Shiroo M; Marshall CJ; Hsuan JJ; Saklatvala J Biochem J; 1994 Sep; 302 ( Pt 3)(Pt 3):897-905. PubMed ID: 7945218 [TBL] [Abstract][Full Text] [Related]
30. Effect of carboxyl terminal truncation on the tyrosine kinase activity of the epidermal growth factor receptor. Wedegaertner PB; Gill GN Arch Biochem Biophys; 1992 Jan; 292(1):273-80. PubMed ID: 1309297 [TBL] [Abstract][Full Text] [Related]
31. Homooligomerization of the cytoplasmic domain of the T cell receptor zeta chain and of other proteins containing the immunoreceptor tyrosine-based activation motif. Sigalov A; Aivazian D; Stern L Biochemistry; 2004 Feb; 43(7):2049-61. PubMed ID: 14967045 [TBL] [Abstract][Full Text] [Related]
32. Characterization of the epidermal growth factor receptor from Ehrlich ascites tumor cells. Elexpuru A; Soriano M; Villalobo A Biol Chem Hoppe Seyler; 1994 Apr; 375(4):293-8. PubMed ID: 8060539 [TBL] [Abstract][Full Text] [Related]
33. In vitro activation of Stat3 by epidermal growth factor receptor kinase. Park OK; Schaefer TS; Nathans D Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13704-8. PubMed ID: 8942998 [TBL] [Abstract][Full Text] [Related]
34. A region in the cytosolic domain of the epidermal growth factor receptor antithetically regulates the stimulatory and inhibitory guanine nucleotide-binding regulatory proteins of adenylyl cyclase. Sun H; Seyer JM; Patel TB Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2229-33. PubMed ID: 7892252 [TBL] [Abstract][Full Text] [Related]
35. Protein-tyrosine-phosphatase-mediated epidermal growth factor (EGF) receptor transinactivation and EGF receptor-independent stimulation of mitogen-activated protein kinase by bradykinin in A431 cells. Graness A; Hanke S; Boehmer FD; Presek P; Liebmann C Biochem J; 2000 Apr; 347(Pt 2):441-7. PubMed ID: 10749673 [TBL] [Abstract][Full Text] [Related]
36. Regulation of the epidermal growth factor receptor by phosphorylation. Bertics PJ; Weber W; Cochet C; Gill GN J Cell Biochem; 1985; 29(3):195-208. PubMed ID: 3001110 [TBL] [Abstract][Full Text] [Related]
37. Mn2(+)-binding properties of a recombinant protein-tyrosine kinase derived from the human insulin receptor. Wente SR; Villalba M; Schramm VL; Rosen OM Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2805-9. PubMed ID: 2157215 [TBL] [Abstract][Full Text] [Related]
38. The full-length, cytoplasmic C-terminus of the beta 2-adrenergic receptor expressed in E. coli acts as a substrate for phosphorylation by protein kinase A, insulin receptor tyrosine kinase, GRK2, but not protein kinase C and suppresses desensitization when expressed in vivo. Doronin S; Lin F; Wang HY; Malbon CC Protein Expr Purif; 2000 Dec; 20(3):451-61. PubMed ID: 11087685 [TBL] [Abstract][Full Text] [Related]
39. Differential induction of phosphatidylcholine hydrolysis, diacylglycerol formation and protein kinase C activation by epidermal growth factor and transforming growth factor-alpha in normal human skin fibroblasts and keratinocytes. Reynolds NJ; Talwar HS; Baldassare JJ; Henderson PA; Elder JT; Voorhees JJ; Fisher GJ Biochem J; 1993 Sep; 294 ( Pt 2)(Pt 2):535-44. PubMed ID: 7690546 [TBL] [Abstract][Full Text] [Related]
40. Epidermal growth factor binding induces a conformational change in the external domain of its receptor. Greenfield C; Hiles I; Waterfield MD; Federwisch M; Wollmer A; Blundell TL; McDonald N EMBO J; 1989 Dec; 8(13):4115-23. PubMed ID: 2591370 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]